COMMUNIQUÉS West-GlobeNewswire

RAMSAY SANTE : modalités de mise à disposition ou de consultation des documents préparatoires à l'Assemblée générale de Ramsay Générale de Santé du 11 décembre 2025
17/11/2025
COMMUNIQUÉ DE PRESSE Paris, le 14 novembre 2025 ASSEMBLEE GENERALE MIXTE DU 11 DECEMBRE 2025 Modalités de mise à disposition ou de consultation des documents préparatoires à l’Assemblée générale de Ramsay Générale de [...]
Clue Expands Wearable Integrations with Withings, Ultrahuman, WHOOP, Huawei, Polar, Fitbit, Noise and Luna, Unlocking Deeper Insights into Women’s Health
17/11/2025
LONDON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clue , the #1 women-led period and cycle tracker trusted by over 100 million worldwide, has today announced expanded integrations with leading wearable partners Withings , [...]
Nxera Pharma Shares Video Interviews with Major Shareholders on Its Official YouTube Channel
17/11/2025
Perspectives from Nxera’s major shareholders provide deeper insights into their investment views and confidence in the Company’s strategy Tokyo, Japan and Cambridge and London, UK, 17 November 2025 – Nxera Pharma Co., [...]
Inventiva announces full exercise of Underwriters’ Option, bringing proceeds of Offering to approximately $172.5M
17/11/2025
Daix (France), New York City (New York, United States), November 17, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (" Inventiva " or the " Company "), a clinical-stage biopharmaceutical company focused on the [...]
Inventiva annonce l’exercice intégral de l’Option des Banques portant le montant de l'Offre à environ 172,5 millions de dollars
17/11/2025
Daix (France), New York City (New York, États-Unis), le 17 novembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Nxera Announces Focused Restructuring to Enhance Path to Profitability
17/11/2025
Tokyo, Japan and Cambridge and London, UK, 17 November 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announced a focused restructuring designed to concentrate investment and resources on [...]
TME Pharma announces receipt of agreements in principle to extend certain bond agreements
17/11/2025
TME Pharma announces receipt of agreements in principle to extend certain bond agreements Berlin, Germany , November 17, 2025, 08.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology [...]
TME Pharma announces receipt of agreements in principle to extend certain bond agreements
17/11/2025
TME PHARMA ANNONCE AVOIR REÇU DES ACCORDS DE PRINCIPE POUR PROLONGER CERTAINS ACCORDS D'OBLIGATIONS Berlin, Allemagne, le 17 novembre 2025, 8h00 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), une société de [...]
James M. O’Brien Appointed Chief Financial Officer at Mesoblast
17/11/2025
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that in connection with the Company’s [...]
Ascend Vitality Expands National Telehealth Network to Provide Physician-Directed Access to Compounded Peptide Therapies
17/11/2025
Sheridan, WY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Ascend Vitality announced today that it has expanded its fully licensed telehealth operations across all 50 states, reinforcing its position as a provider of physician- [...]
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
17/11/2025
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) US FDA clearance now allows use of the ARC-EX ® System both in clinics and homes ARC- [...]
CFO Tania Micki to leave Tecan for new role in 2026
17/11/2025
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland, November 17, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today announced that Tania Micki, Chief [...]
Agomab Announces Positive Topline Phase 2a Data for Ontunisertib in Fibrostenosing Crohn’s Disease
17/11/2025
-- STENOVA trial achieves primary endpoint in 103 study participants after 12 weeks of treatment -- -- Pharmacokinetic results confirm gut-restricted profile of ontunisertib in FSCD patients -- -- Positive efficacy [...]
No Crap In It Launches Limited Holiday Christmas Collection and New Primal Super Blend Supplement, Expanding Its All-Natural Wellness Line
17/11/2025
Willis, TX, Nov. 16, 2025 (GLOBE NEWSWIRE) -- No Crap In It, an all-natural wellness and beauty brand proudly made in Texas has announced the launch of its Limited Holiday Collection – a festive new line of clean label [...]
Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy
16/11/2025
Shareholders approved all proposals, confirming Faraday Future Intelligent Electric Inc. (“Faraday Future”) as the Company’s new majority and controlling shareholder. Faraday Future will nominate a majority of board [...]
NooCube | Nootropics Brain Booster 2025: Lunch Noocube Brain Productivity Pills for Memory, Focus, Read Ingredients & Side Effects.
16/11/2025
NooCube Effective Nootropics Brain Health Supplement Read NooCube ingredients, Side Effects, Benefits | Does the NooCube really work? New York City, Nov. 16, 2025 (GLOBE NEWSWIRE) -- November 14, 2025, Noocube Brain [...]
Vnzymes Opens New European Office in Frankfurt to Accelerate Innovation in Animal Nutrition and Sustainable Agriculture
15/11/2025
FRANKFURT, Germany, Nov. 15, 2025 (GLOBE NEWSWIRE) -- Vnzymes, the new brand and European subsidiary of VTR Biotech Group, today officially announced the grand opening of its office in Frankfurt, marking a significant [...]
Sapphire RX Expands Access to Virtual Wellness Care
15/11/2025
KNOXVILLE, Tenn., Nov. 15, 2025 (GLOBE NEWSWIRE) -- Sapphire RX advances digital health accessibility with an innovative telehealth model that prioritizes patient privacy, medical oversight, and personalized care for [...]
Algernon Closes First Tranche of its Recently Announced Private Placement Financing
15/11/2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) ( [...]

Pages

Other news

Promaxo Announces Closing of Series C Financing and $100M Credit Facility

The growth capital will expand manufacturing capacity, reduce backlog, and support new regulatory filings

ProKidney to Host Virtual KOL Event to Recap Mechanism of Action Data Presented at ASN Kidney Week and Provide a Corporate Update

WINSTON-SALEM, N.C., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ProKidney Corp.

BreathiZen Introduces BreathiZen Spray - A New Multi-Ingredient Dietary Supplement For Your Respiratory Wellness

BreathiZen is a once-daily oral spray that brings together botanical extracts, an enzyme preparation, and selected nutrients in a 60 ml bottle designed to fit easily into an adult wellness routine.

New York, Oct. 22, 2026 (GLOBE NEWSWIRE) --

RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026

Company to host conference call on November 5, 2026, at 4:30 p.m. ET

BridgeBio to Report Third Quarter 2026 Financial Results and Commercial Updates on October 29, 2026 at 4:30 pm ET

PALO ALTO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc.

Ernexa Therapeutics Highlights ERNA-101’s Path Toward the Clinic and Differentiated Cell Therapy Platform in New “What This Means” Segment

Leadership discusses recent FDA engagement, the technology underlying ERNA-101 and the development strategy supporting planned first-in-human clinical evaluation

SciSparc: Subsidiary NeuroThera Labs Reports Positive Progress in FDA-Approved Phase IIb Clinical Trial for Tourette Syndrome

TEL AVIV, Israel, Oct. 22, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary, NeuroThera Labs Inc.